Furthermore, GSK-3β dysfunction is related to the pathophysiology of mood disorders, schizophrenia, diabetes, cancer, inflammation, AD; and may be involved in cannabinoid-induced dependence resulting to induce withdrawal signs, excitation and neuronal plasticity/injury status (24-26). Here, GSK3B is linked to Alzheimer disease.